======= CHST11 =======
== Gene Information ==
* **Official Symbol**: CHST11
* **Official Name**: carbohydrate sulfotransferase 11
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=50515|50515]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPF2|Q9NPF2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CHST11&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHST11|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610128|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene belongs to the sulfotransferase 2 family. It is localized to the golgi membrane, and catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage, and is distributed on the surfaces of many cells and extracellular matrices. A chromosomal translocation involving this gene and IgH, t(12;14)(q23;q32), has been reported in a patient with B-cell chronic lymphocytic leukemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011].
* **UniProt Summary**: Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Can also sulfate Gal residues in desulfated dermatan sulfate. Preferentially sulfates in GlcA->GalNAc unit than in IdoA->GalNAc unit. Does not form 4, 6- di-O-sulfated GalNAc when chondroitin sulfate C is used as an acceptor.
|Sulfotransfer 2|
|N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity|
|polysaccharide localization|
|chondroitin 4-sulfotransferase activity|
|N-acetylgalactosamine 4-O-sulfotransferase activity|
|embryonic viscerocranium morphogenesis|
|post-anal tail morphogenesis|
|chondroitin sulfate biosynthetic process|
|chondroitin sulfate proteoglycan biosynthetic process|
|sulfotransferase activity|
|chondroitin sulfate metabolic process|
|respiratory gaseous exchange by respiratory system|
|chondrocyte development|
|chondroitin sulfate proteoglycan metabolic process|
|embryonic cranial skeleton morphogenesis|
|embryonic digit morphogenesis|
|cranial skeletal system development|
|proteoglycan biosynthetic process|
|negative regulation of transforming growth factor beta receptor signaling pathway|
|negative regulation of cellular response to transforming growth factor beta stimulus|
|chondrocyte differentiation|
|post-embryonic development|
|proteoglycan metabolic process|
|embryonic skeletal system morphogenesis|
|glycosaminoglycan biosynthetic process|
|mucopolysaccharide metabolic process|
|aminoglycan biosynthetic process|
|regulation of transforming growth factor beta receptor signaling pathway|
|regulation of cellular response to transforming growth factor beta stimulus|
|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|embryonic limb morphogenesis|
|embryonic appendage morphogenesis|
|embryonic skeletal system development|
|carbohydrate biosynthetic process|
|negative regulation of cellular response to growth factor stimulus|
|limb morphogenesis|
|appendage morphogenesis|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|cartilage development|
|appendage development|
|limb development|
|sulfur compound biosynthetic process|
|connective tissue development|
|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|skeletal system morphogenesis|
|regulation of cellular response to growth factor stimulus|
|embryonic organ morphogenesis|
|glycoprotein biosynthetic process|
|sulfur compound metabolic process|
|in utero embryonic development|
|glycoprotein metabolic process|
|developmental growth|
|growth|
|embryonic organ development|
|carbohydrate metabolic process|
|skeletal system development|
|embryonic morphogenesis|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|animal organ morphogenesis|
|embryo development|
|negative regulation of cell death|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|organonitrogen compound biosynthetic process|
|regulation of apoptotic process|
|regulation of programmed cell death|
|regulation of cell population proliferation|
|negative regulation of response to stimulus|
|cell development|
|regulation of cell death|
|cellular macromolecule biosynthetic process|
|small molecule metabolic process|
|tissue development|
|macromolecule biosynthetic process|
|membrane|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16522
* **Expression level (log2 read counts)**: 6.59
{{:chemogenomics:nalm6 dist.png?nolink |}}